Long-term follow-up study on obstructive hypertrophic cardiomyopathy patients treated with disopyramide: evidences of a notable trend in symptom control within a real-world clinical setting

Long-term follow-up study on obstructive hypertrophic cardiomyopathy patients treated with disopyramide: evidences of a notable trend in symptom control within a real-world clinical setting

BackgroundIn obstructive hypertrophic cardiomyopathy (HOCM), disopyramide is used in patients who remain symptomatic despite β-blockers or verapamil. However, effectiveness of disopyramide therapy has not been clearly established due to inconsistent definition of responders and the insufficient leng...

Full description

Bibliographic Details
Main Authors: Gaetano Todde, Lorenzo Lupo Dei, Roberto Polizzi, Domenico Gabrielli, Grazia Canciello, Silvio Romano, Felice Borrelli, Geza Halasz, Leopoldo Ordine, Salvatore Di Napoli, Daniela Pacella, Raffaella Lombardi, Giovanni Esposito, Federica Re, Maria-Angela Losi
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-08-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
hypertrophic cardiomyopathy
disopyramide
obstruction
therapy
symptoms
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2024.1416600/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2024.1416600/full

Similar Items